18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus

18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus

Background: Idiopathic normal pressure hydrocephalus (iNPH) is an important and treatable cause of neurologic impairment. Diagnosis is complicated due to symptoms overlapping with other age related disorders. The pathophysiology underlying iNPH is not well understood. We explored FDG-PET abnormaliti...

Full description

Bibliographic Details
Main Authors:	Ryan A. Townley, Hugo Botha, Jonathan Graff-Radford, Bradley F. Boeve, Ronald C. Petersen, Matthew L. Senjem, David S. Knopman, Val Lowe, Clifford R. Jack, Jr, David T. Jones
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Series:	NeuroImage: Clinical
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213158218300652

Similar Items

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
by: Kejal Kantarci, et al.
Published: (2021-01-01)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET
by: Nick Corriveau-Lecavalier, et al.
Published: (2024-01-01)

Automated detection of imaging features of disproportionately enlarged subarachnoid space hydrocephalus using machine learning methods
by: Nathaniel B. Gunter, et al.
Published: (2019-01-01)

Face recognition from research brain PET: An unexpected PET problem
by: Christopher G. Schwarz, et al.
Published: (2022-09-01)

Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
by: Irene Sintini, et al.
Published: (2019-01-01)

FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
by: Ajay Madhavan, et al.
Published: (2013-01-01)

Elevated medial temporal lobe and pervasive brain tau‐PET signal in normal participants
by: Val J. Lowe, et al.
Published: (2018-01-01)

The metabolic spatial covariance pattern of definite idiopathic normal pressure hydrocephalus: an FDG PET study with principal components analysis
by: Alexander Rau, et al.
Published: (2023-11-01)

FDG-PET/CT in lymphoma
by: Maria M D′souza, et al.
Published: (2013-01-01)

18F-FDG PET/CT Findings in Cytomegalovirus Colitis
by: Anna Sophie L. Kjaer, et al.
Published: (2018-12-01)

Diagnosis of an unusual case of idiopathic mediastinal fibrosis by 18F-FDG PET/CT
by: Roberto G. Carbone, MD, et al.
Published: (2020-04-01)

18F-FDG PET/CT of cervical carcinoma.
by: Patel, C, et al.
Published: (2011)

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
by: Chowdhury, F, et al.
Published: (2008)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
by: Shim Young-Soo, et al.
Published: (2011-03-01)

Comparison of [18F]Flutemetamol and [11C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
by: Val J. Lowe, et al.
Published: (2017-01-01)

18F-FDG PET/CT Findings in a Patient with Chikungunya Virus Infection
by: Michala Vaaben Rose, et al.
Published: (2017-08-01)

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
by: Aurélien Justet, et al.
Published: (2017-04-01)

Application of FDG-PET/CT in Radiation Oncology
by: Jun eLi, et al.
Published: (2013-04-01)

Usefulness of FDG PET/CT in the management of tuberculosis.
by: Adrián Sánchez-Montalvá, et al.
Published: (2019-01-01)

FDG PET/CT in the detection of infections and inflammations
by: Artiko Vera
Published: (2012-01-01)

Appropriateness criteria of FDG PET/CT in oncology
by: Archi Agrawal, et al.
Published: (2015-04-01)

PET/CT in Multiple Myeloma: Beyond FDG
by: Federica Matteucci, et al.
Published: (2021-01-01)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
by: Keith A. Josephs, et al.
Published: (2020-05-01)

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers
by: Petrice M. Cogswell, et al.
Published: (2021-01-01)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
by: David Groshar, et al.
Published: (2017-04-01)

CT and FDG-PET/CT findings in progressive mediastinal idiopathic fibrosis as a benign mimicker of esophageal carcinoma: a case report
by: Milica Mitrovic-Jovanovic, et al.
Published: (2023-12-01)

Applications of 18(F) FDG PET/CT in oncology
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

Scar sarcoidosis on 18F-FDG PET/CT
by: Saurabh Arora, et al.
Published: (2019-06-01)

FDG-PET/CT in predicting aggressiveness of rectal cancer
by: Iman Sherif Ahmed, et al.
Published: (2021-11-01)

Diagnosis of an intestinal mucormycosis ‘fungus ball’ located with PET/CT with [18F] FDG-PET/CT
by: Franklin Gallo, et al.
Published: (2019-12-01)

A rare case of idiopathic granulomatous hepatitis presenting as tumoral lesion detected by 18F-FDG-PET/CT
by: Gaetano Paone, M.D., et al.
Published: (2016-01-01)

18F-FDG PET/CT Findings in Acute Epstein-Barr Virus Infection Mimicking Malignant Lymphoma
by: Mathilde Ørbæk, et al.
Published: (2016-05-01)

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT
by: Karim Amrane, et al.
Published: (2022-12-01)

Amelanotic melanoma detected by 18F-FDG PET-CT
by: Ningning Chen, et al.
Published: (2024-04-01)

Primary pancreatic Ewing sarcoma with metastases on FDG PET/CT
by: Man Mohan Singh, et al.
Published: (2023-09-01)

FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
by: Jonathan D. West MD, et al.
Published: (2021-11-01)

FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis
by: Catherine Bullock, MD, et al.
Published: (2023-11-01)

Survival effect of pretreatment FDG-PET–CT on nasopharyngeal cancer
by: Pei-Chen Yang, et al.
Published: (2023-01-01)

18F FDG PET-CT in oncology & interesting images
by: Ahmad Saad, Fathinul Fikri
Published: (2015)

18FDG PET/CT in pulmonary carcinosarcoma and brain metastasis
by: Hamideh Abbasian, et al.
Published: (2019-06-01)